Developmental Research Plan

发展研究计划

• 批准号: 7675518
• 负责人: Michael Joseph Buchmeier
• 金额: $ 49.22万
• 依托单位: UNIVERSITY OF CALIFORNIA-IRVINE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7675518
• 关键词: Arizona; California; Core Facility; Data; Development; Diagnostic tests; Emerging Communicable Diseases; Emerging Technologies; Funding; Hawaii; Infection; Infectious Diseases Research; Institution; Mission; Nevada; Pilot Projects; Prevention; Recruitment Activity; Research; Research Personnel; Research Project Grants; Translational Research; United States National Institutes of Health; biodefense; meetings; novel; sound; success

The overall priorities for the PSWRCE's development activity are reflected in these questions asked of each application: (a) Is the proposal novel and exciting? (b) Is the research plan hypothesis-driven, sound in its inferences and reasoning, and compelling in its presentation? (c) In the absence of preliminary data¿which is encouraged but not be required¿does the accomplishments of the proposer to date and the strength of her/his argument inspire confidence about the project's success? (d) Will the proposed project likely contribute to the national biodefense mission? (e) Should the proposal meet criteria a-d, is it then complementary or synergistic rather than duplicative or irrelevant to on-going RCE projects? (f) Could the pilot project develop into a full RCE project or into a competitive research NIH application? (g) For those proposing translation of research, how likely is a product or "deliverable", such as diagnostic test, new therapy, or means of prevention? (h) Does the proposal provide for the recruitment of new investigators and institutions, currently not participating in the PSWRCE? (i) Will the proposed study utilize PSWRCE core facilities?

社会福利和经济研究中心发展活动的总体优先事项反映在以下问题中： 每项申请：（a）建议是否新颖和令人兴奋？(b)研究计划是否以假设为导向， 推论和推理，并在其介绍令人信服？(c)在缺乏初步数据的情况下， 鼓励但不要求：申请人迄今为止的成就和她/他的实力 争论激发了对项目成功的信心？(d)拟议项目是否可能有助于 国家生物防御使命(e)如果提案符合标准a-d，那么它是互补还是协同 而不是重复或与正在进行的RCE项目无关？(f)试点项目能否发展成为一个全面的 RCE项目还是转化为竞争性研究NIH申请？(g)对于那些建议翻译研究的人来说， 一种产品或“可交付”，如诊断测试、新疗法或预防手段，可能性有多大？(h)并 该提议规定征聘新调查员和机构， PSWRCE？(i)拟议的研究是否会使用PSWRCE核心设施？